Carter Robert Ross 4
4 · Oncology Institute, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Carter Robert Ross
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-02$3.56/sh−247$879→ 235,122 total
Footnotes (1)
- [F1]The reporting person used the proceeds of this sale to cover tax liabilities arising from the vesting of an RSU award on January 1, 2026.